Lost in the labyrinthSeptember 05, 2006Decoding the instructions that tell cells how to become blood Blood cells have limited lifespans, which means that they must be continually replaced by calling up reserves, and turning these into the blood cell types needed by the body. Claus Nerlov and his colleagues at the European Molecular Biology Laboratory (EMBL) unit in Monterotondo, Italy, in collaboration with researchers from Sten Eirik Jacobsen's laboratory at the University of Lund in Sweden, have now uncovered how an intracellular communication pathway contributes to this process. Because defects in such pathways and in the development of stem cells frequently lead to leukemia and other diseases, the work should give researchers a new handle on processes within cells that lead to cancer. The work is published in this week's online issue of Nature Immunology. Over the past decades, molecular biologists have identified several pathways - sequences of molecules which manage the flow of information within the cell - responsible for major biological processes. One of these, the "Wingless" pathway, plays a vital role in shaping tissues and organs in developing embryos of nearly all animal species. It also helps organisms manage stem cells, by keeping them on hold and preventing their differentiation until the right time. Such pathways are usually switched on and off by external stimuli that help cells respond properly to the environment. Now Peggy Kirstetter and other members of Nerlov's lab have shown what happens when Wingless is too active in hematopoietic stem cells in mice. "We modified one element of the pathway, a protein called beta-catenin, so that it was stuck in 'transmission mode,'" Kirstetter says. "This created cells in which the pathway was always switched on. We've known that Wingless contributes to blood differentiation, but didn't know how the signals were being transmitted within the hematopoietic stem cell." The modified protein had dramatic effects. Usually, most cells undergo numerous transitional stages on their way from stem cells to fully-developed types in the blood. Several types of blood cells vanished entirely; the same thing happened to more basic cell types higher up in the blood lineage hierarchy. Particular kinds of stem cells disappeared from the bone marrow of the mice. Others were too frequent. Bone marrow cells didn't develop into myeloid and red blood cells. B- and T-cells were also blocked at early stages, but in a different way. This hints that they may be controlled by other protein links in the Wingless pathway as well. Perhaps most strikingly, beta-catenin appears to make cells take decisions about their fate before they leave the stem cell compartment in the bone marrow, something so far not thought to occur. The study proves that beta-catenin plays a central role in determining whether blood cells form or not. On the other hand, an overactive Wingless pathway doesn't seem to damage cells that already exist. Thus beta-catenin seems to be a decision-maker, a selector of how information gets routed within the cell, rather than something which maintains the vitality of existing cells. Nerlov compares the breakdown to people standing at a fork in a labyrinth, hesitating before they go on. "We know there are strong connections to cells' decisions to divide, to develop or to die. If cells don't commit themselves to the right developmental path at the right time, they're very likely to die or to begin an inappropriate type of reproduction. Acute leukemias and other forms of cancer cells derive from defects such as this. Understanding the processes by which they form will require pinpointing the forks in the road where things go wrong." European Molecular Biology Laboratory |
|||||||||||||||||||||
| Related Blood Cells Current Events and Blood Cells News Articles Researchers Identify Role of Gene in Tumor Development, Growth and Progression Virginia Commonwealth University Massey Cancer Center and VCU Institute of Molecular Medicine researchers have identified a gene that may play a pivotal role in two processes that are essential for tumor development, growth and progression to metastasis. Measuring and modeling blood flow in malaria When people have malaria, they are infected with Plasmodium parasites, which enter the body from the saliva of a mosquito, infect cells in the liver, and then spread to red blood cells. New cancer target for non-Hodgkin's lymphoma Physician-scientists from Weill Cornell Medical College have discovered a molecular mechanism that may prove to be a powerful target for the treatment of non-Hodgkin's lymphoma, a type of cancer that affects lymphocytes, or white blood cells. New research into the mechanisms of gene regulation A team led by Penn State's Ross Hardison, T. Ming Chu Professor of Biochemistry and Molecular Biology, has taken a large step toward unraveling how regulatory proteins control the production of gene products during development and growth. Sweet -- sugared polymer a new weapon against allergies and asthma Scientists at Johns Hopkins and their colleagues have developed sugar-coated polymer strands that selectively kill off cells involved in triggering aggressive allergy and asthma attacks. New mechanism explains how the body prevents formation of blood vessels Researchers at Uppsala University, in collaboration with colleagues in Sweden and abroad, have identified an entirely new mechanism by which a specific protein in the body inhibits formation of new blood vessels. Scientists successfully reprogram blood cells Researchers have transplanted genetically modified hematopoietic stem cells into mice so that their developing red blood cells produce a critical lysosomal enzyme -preventing or reducing organ and central nervous system damage from the often-fatal genetic disorder Hurler's syndrome. Hundreds of genes distinguish patients likely to survive advanced melanoma Although the chances of surviving advanced melanoma aren't very good with current therapies, some patients can live for years with cancer that has spread beyond the skin to other organs. First use of antibody and stem cell transplantation to successfully treat advanced leukemia For the first time, researchers at Fred Hutchinson Cancer Research Center have reported the use of a radiolabeled antibody to deliver targeted doses of radiation, followed by a stem cell transplant, to successfully treat a group of leukemia and pre-leukemia patients for whom there previously had been no other curative treatment options. Magnetic nanoparticles to simultaneously diagnose, monitor and treat Whether it's magnetic nanoparticles (mNPs) giving an army of 'therapeutically armed' white blood cells direction to invade a deadly tumour's territory, or the use of mNPs to target specific nerve channels and induce nerve-led behaviour (such as the life-dependant thumping of our hearts), mNPs have come a long way in the past decade. More Blood Cells Current Events and Blood Cells News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||